Valeant Pharmaceuticals Intl Inc Stock Price (NYSE:VRX)

Add to My Stocks
$14.23 $0.16 (1.14%) VRX stock closing price Sep 21, 2017 (Closing)
Prev Close* : $14.07
Market Cap:
$4.9B
Day Low: $13.86
52 Week Low: $8.31
Open: $14.07
Volume: 6225626
Day High: $14.41
52 Week High: $27.84
Dividend:
N/A

Valeant Pharmaceuticals Intl Inc Stock Articles & Video

more news on VRX stock

Valeant Pharmaceuticals Intl Inc News - From Partners

VRX Stockcharts

View VRX PE ratio, PS ratio stocks charts and compare with peers.
VRX Chart
Note: Compare Valeant Pharmaceuticals Intl Inc stock price history with the index and industry peers.

Valeant Pharmaceuticals Intl Inc Valuation

PS ratio (
price to sales ratio
)
0.53
PB ratio (
price to book ratio
)
1.17

Valeant Pharmaceuticals Intl Inc Financial Ratios

Asset Turnover
0.21
Receivables Turnover
3.8
Debt to Equity
7.06

VRX Industry Peers

Company Price Change (%)
Neurocrine Biosciences (NBIX)58.832.03 (3.57%)
Nps Pharma (NPSP)45.970 (0%)
Glaxosmithkline (GSK)40.330.15 (0.37%)
Novartis (NVS)84.940.84 (0.98%)
Johnson & Johnson (JNJ)131.751.47 (1.1%)
Pfizer (PFE)35.970.02 (0.06%)
Astrazeneca (AZN)32.810.12 (0.36%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AVADEL PHARMA (AVDL)9.60.4 (4.35%)
Lannett Co (LCI)17.350.7 (4.2%)
Neurocrine Biosciences (NBIX)58.832.03 (3.57%)
Flexion Therapeutics (FLXN)26.680.91 (3.53%)
CTI BioPharma (CTIC)3.280.08 (2.5%)
Durect (DRRX)1.690.04 (2.42%)
Nektar Therapeutics (NKTR)21.870.48 (2.24%)
Top gainers from Medical-Drugs industry
* As of Sep 22, 2017
CompanyPriceChange (%)
Karyopharm Therapeutics (KPTI)10.480.68 (6.09%)
Zogenix (ZGNX)13.050.55 (4.04%)
Ionis Pharma (IONS)51.832.05 (3.8%)
Regulus Therapeutics (RGLS)1.320.05 (3.65%)
Aerie Pharma (AERI)51.451.95 (3.65%)
Ignyta (RXDX)12.40.4 (3.13%)
Achaogen (AKAO)15.740.44 (2.72%)
Top losers from Medical-Drugs industry
* As of Sep 22, 2017

Valeant Pharmaceuticals Intl Inc Stock News - Partner Headlines

Valeant Pharmaceuticals Intl Inc Financial Statements

income statement20162015201420132012
Net Sales or Revenues9.67B10.45B8.26B5.77B3.55B
Net Income-2.41B-291.7M913.5M-866.14M-116.02M
Total Operating Expense7.63B6.33B3.97B4.27B2.43B
View Valeant Pharmaceuticals Intl Inc income statement
balance sheet20162015201420132012
Total Assets43.53B48.96B26.35B27.97B17.95B
Total Liabilities40.27B42.93B20.92B22.74B14.23B
Shareholders Equity3.26B6.03B5.43B5.23B3.72B
View Valeant Pharmaceuticals Intl Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-110M-822.2M-668.4M-378.29M-253.27M
Net Cash from (used by) Operating Activities2.09B2.2B2.29B1.04B656.57M
Increase (Decrease) in Prop Plant And Equipment-36M-222.4M1.2B-74.22M-15.64M
View Valeant Pharmaceuticals Intl Inc cash flow statement

Valeant Pharmaceuticals Intl Inc Stock Message Board

Valeant Pharmaceuticals Intl Inc stock lost 1.14 %, and the last close price as of 21 Sep, 2017 is 14.23 for VRX stock. Valeant Pharmaceuticals Intl Inc market capitalization is 4.9B and it represents the total market value of VRX stock. Valeant Pharmaceuticals Intl Inc valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Valeant Pharmaceuticals Intl Inc stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 6225626 VRX shares were traded yesterday, and Valeant Pharmaceuticals Intl Inc stock chart shows that the VRX stock quote hit a day high of 14.41 and day low of 13.86. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Valeant Pharmaceuticals Intl Inc stock price history, gives the entire historical data for VRX stock.